Evaluation on clot buster activity of staphylokinase from Staphylococcus sp.

@article{Mohanasrinivasan2014EvaluationOC,
  title={Evaluation on clot buster activity of staphylokinase from Staphylococcus sp.},
  author={Vaithiyalingam Mohanasrinivasan and C. Subathra Devi and Sukanya Saha and Lubbnaz Nagarchi and Batmanabane Prakash Vaishnavi and S. Jemimah Naine},
  journal={Cardiovascular & hematological agents in medicinal chemistry},
  year={2014},
  volume={12 2},
  pages={86-90}
}
Thrombolytic agents play a major role in the treatment of cardiovascular diseases. Streptokinase is the prominently commercialized thrombolytic drug used for the treatment of cardiovascular diseases. The later studies on staphylokinase (SaK) showed promising results as an alternative fibrinolytic drug. The present study explores the isolation, production… CONTINUE READING